Skip to main content

Advertisement

Log in

Association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population: a case control study

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-aged women. PCOS reflects a number of possible etiologies but its pathophysiology is still unclear. The principal abnormality of the syndrome is hyperandrogenism (70–80%). The access of androgens to target tissues is regulated by sex hormone-binding globulin (SHBG), a transport protein secreted by liver i.e. specific for androgens. Present study was done to find the association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population. Present study was a case control study. 400 subjects were enrolled for the study and serum SHBG levels and D327N polymorphism were measured. The D327N polymorphism (wild-type and variant allele) was detected using PCR-RFLP method (restriction enzyme Bbs-I). PCOS group was found to have significantly lower SHBG levels than healthy controls. There was no significant difference in genotype distribution between PCOS and controls (χ2 = 1.0335, p = 0.59). Significant difference in SHBG levels of PCOS and control group highlights the potential of SHBG as a biomarker for PCOS. However, no significant difference in genotype distribution between PCOS and controls provided an insight that rs6259 polymorphism is not associated with the risk of PCOS and SHBG levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pugeat M, Crave JC, Tourniaire J et al (1996) Clinical utility of sex hormone-binding globulin measurement. Horm Res Paediatr 45:148–155

    Article  CAS  Google Scholar 

  2. Anderson DC (1974) Sex-hormone-binding globulin. Clin Endocrinol 3:69–96

    Article  CAS  Google Scholar 

  3. Rosner W (1991) Plasma steroid-binding proteins. Endocrinol Metab Clin North Am 20:697–720

    Article  CAS  PubMed  Google Scholar 

  4. Dunaif A, Segal KR, Futterweit W et al (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165–1174

    Article  CAS  PubMed  Google Scholar 

  5. Bozdag G, Mumusoglu S, Zengin D et al (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31:2841–2855

    Article  PubMed  Google Scholar 

  6. Rotterdam ES, ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41

    Article  Google Scholar 

  7. Alexiou E, Hatziagelaki E, Pergialiotis V et al (2017) Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index. Horm Mol Biol Clin Investig 29:105–111

    CAS  PubMed  Google Scholar 

  8. Kalyani RR, Franco M, Dobs AS et al (2009) The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 94:4127–4135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Le TN, Nestler JE, Strauss JF et al (2012) Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab 23:32–40

    Article  CAS  PubMed  Google Scholar 

  10. Zha XY, Hu Y, Pang XN et al (2016) The association between sex hormone-binding globulin gene polymorphism with bone mineral density. Steroids 106:9–18

    Article  CAS  PubMed  Google Scholar 

  11. El Tarhouny SA, Zakaria SS, Abdu-Allah AM et al (2015) Study of sex hormone-binding globulin gene polymorphism and risk of type 2 diabetes mellitus in Egyptian men. West Indian Med J 64:338

    PubMed  Google Scholar 

  12. .Zhang LS, Yuan F, Guan X et al (2014) Association of genetic polymorphisms in HSD17B1, HSD17B2 and SHBG genes with hepatocellular carcinoma risk. Pathol Oncol Res 20:661–666

    Article  CAS  PubMed  Google Scholar 

  13. Xu WH, Zheng W, Cai Q et al (2008) The Asp 327 Asn polymorphism in the sex hormone-binding globulin gene modifies the association of soy food and tea intake with endometrial cancer risk. Nutr Cancer 60:736–743

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Safarinejad MR, Shafiei N, Safarinejad S (2011) Association of the (TAAAA) n repeat and Asp327Asn polymorphisms in the sex hormone-binding globulin (SHBG) gene with idiopathic male infertility and relation to serum SHBG concentrations. J Steroid Biochem Mol Biol 123:37–45

    Article  CAS  PubMed  Google Scholar 

  15. Bendlová B, Zavadilová J, Vaňková M et al (2007) Role of D327N sex hormone-binding globulin gene polymorphism in the pathogenesis of polycystic ovary syndrome. J Steroid Biochem Mol Biol 104:68–74

    Article  CAS  PubMed  Google Scholar 

  16. Martínez-García M, Gambineri A, Alpañés M et al (2012) Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women. Hum Reprod 27:3569–3576

    Article  CAS  PubMed  Google Scholar 

  17. Wickham EP III, Ewens KG, Legro RS et al (2011) Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 96:E719–E727

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hacıhanefioğlu B, Aybey B, Hakan Özön Y et al (2013) Association of anthropometric, androgenic and insulin-related features with polymorphisms in exon 8 of SHBG gene in women with polycystic ovary syndrome. Gynecol Endocrinol 29:361–364

    Article  CAS  PubMed  Google Scholar 

  19. Thaler MA, Seifert-Klauss V, Luppa PB (2015) The biomarker sex hormone-binding globulin—from established applications to emerging trends in clinical medicine. Best Pract Res Clin Endocrinol Metab 29:749–760

    Article  CAS  PubMed  Google Scholar 

  20. Toljan K, Grgić F, Pavičić Baldani D et al (2016) Sex hormone binding globulin (SHBG) as a marker of clinical disorders. Coll Antropol 40:199–209

    Google Scholar 

  21. Fabbri E, An Y, Gonzalez-Freire M et al (2016) Bioavailable testosterone linearly declines over a wide age spectrum in men and women from the Baltimore longitudinal study of aging. J Gerontol A Biol Sci Med Sci 71:1202–1209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Azrad M, Gower BA, Hunter GR et al (2012) Intra-abdominal adipose tissue is independently associated with sex-hormone binding globulin in premenopausal women. Obesity 20:1012–1015

    Article  CAS  PubMed  Google Scholar 

  23. Kim JS, Kang HT, Shim JY (2012) The association between the triglyceride to high-density lipoprotein cholesterol ratio with insulin resistance (HOMA-IR) in the general Korean population: based on the National Health and Nutrition Examination Survey in 2007–2009. Diabetes Res Clin Pract 97:132–138

    Article  CAS  PubMed  Google Scholar 

  24. Azziz R, Carmina E, Dewailly D et al (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456–488

    Article  PubMed  Google Scholar 

  25. Abu-Hijleh TM, Gammoh E, Al-Busaidi AS et al (2016) Common variants in the sex hormone-binding globulin (SHBG) gene influence SHBG levels in women with polycystic ovary syndrome. Ann Nutr Metab 68:66–74

    Article  CAS  PubMed  Google Scholar 

  26. White MJ, Eren F, Agirbasli D et al (2015) SHBG gene polymorphism (rs1799941) associates with metabolic syndrome in children and adolescents. PLoS ONE 10:e0116915

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Baldani DP, Skrgatic L, Cerne JZ et al (2015) Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome. Mol Med Rep 11:3941–3947

    Article  CAS  PubMed  Google Scholar 

  28. Markatseli AE, Hatzi E, Pamporaki C et al (2014) Association of the (TAAAA) n repeat polymorphism of SHBG gene with the age at menopause in Greek postmenopausal women. Maturitas 78:113–116

    Article  CAS  PubMed  Google Scholar 

  29. Svartberg J, Schirmer H, Wilsgaard T et al (2014) Single-nucleotide polymorphism, rs1799941 in the sex hormone-binding globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in men: the Tromsø study. Andrology 2:212–218

    Article  CAS  PubMed  Google Scholar 

  30. Sunbul M, Eren F, Nacar C et al (2013) Sex hormone binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women. Cardiol J 20:287–293

    Article  PubMed  Google Scholar 

  31. Monteiro C, Sousa MV, Ribeiro R et al (2013) Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer. Med Oncol 30:490

    Article  CAS  PubMed  Google Scholar 

  32. Saltiki K, Stamatelopoulos K, Voidonikola P et al (2011) Association of the SHBG gene promoter polymorphism with early markers of atherosclerosis in apparently healthy women. Atherosclerosis 219:205–210

    Article  CAS  PubMed  Google Scholar 

  33. Vanková M, Prazáková S, Lukásová P et al (2010) Extremely low SHBG level in consequence of Pro156Leu SHBG polymorphism—case reports of two women with polycystic ovary syndrome. Vnitrni Lekarstvi 56:1292–1295

    PubMed  Google Scholar 

  34. Xita N, Milionis HJ, Galidi A et al (2011) The (TAAAA) n polymorphism of the SHBG gene in men with the metabolic syndrome. Exp Clin Endocrinol Diabetes 119:126–128

    Article  CAS  PubMed  Google Scholar 

  35. Piotrowski P, Gasik R, Lianeri M et al (2010) Asp327Asn polymorphism of sex hormone-binding globulin gene is associated with systemic lupus erythematosus incidence. Mol Biol Rep 37:235–239

    Article  CAS  PubMed  Google Scholar 

  36. Cousin P, Calemard-Michel L, Lejeune H et al (2004) Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women. J Clin Endocrinol Metab 89:917–924

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Authors acknowledge DST-INSPIRE division and DBT-HRD to support the research work and Centre for Medical biotechnology, MDU, Rohtak, Haryana, India to provide a research platform to carry out research work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amita S. Dang.

Ethics declarations

Conflict of interest

Authors declare no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

11033_2019_4665_MOESM1_ESM.doc

Supplementary material 1 Fig. 1 Study Population segregation: study population was screened according to Rotterdam criteria. SHBG levels measurement and PCR-RFLP pattern was analyzed; Subjects were also segregated on BMI to find its association with polymorphism under study. PCOS patients were segregated on the basis of presence and absence of Hyperandrogenism (HA) to evaluate the role of rs6259 in predisposition of hyperandrogenism as well. Fig. 2 Receiver’s Operative curve for SHBG as a diagnostic marker for PCOS: Significant difference in PCOS (Poly Cystic Ovary Syndrome) and control population highlights the potential of SHBG (Sex hormone binding globulin) to be used as a diagnostic marker for the identification of the syndrome ROC curve with a specificity and sensitivity 93.51 and 99.38% respectively. Fig. 3 Receiver’s Operative curve for SHBG as a susceptibility marker for PCOS: Reduced SHBG (Sex hormone binding globulin) levels were found in obese PCOS (Poly Cystic Ovary Syndrome) patients than lean PCOS patients. Hence it can be predicted as a marker to differentiate obese and lean population with a specificity and sensitivity score 90.57 and 98.67% respectively. Fig. 4 Receiver’s Operative curve for SHBG as a phenotypic differential marker for PCOS: SHBG (Sex hormone binding globulin) levels were low in Hyperandrogenic PCOS patients than Non hyperandrogenic PCOS (Poly Cystic Ovary Syndrome) subjects. The result can be used as a marker with a specificity and sensitivity score 94.69 and 97.31% respectively. Supplementary Fig. 5 Restriction analysis of PCR product on 3% agarose gel: Lane 1: 50 bp ladder, lane 2: AA genotype (290 bp), Lane3 and 5: GG genotype (223 bp product and 67 bp product: not visible), lane 4: GA genotype (290,223, 67 bp digested product) (DOC 224 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhatnager, R., Senwal, A., Nanda, S. et al. Association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population: a case control study. Mol Biol Rep 46, 2131–2138 (2019). https://doi.org/10.1007/s11033-019-04665-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-019-04665-2

Keywords

Navigation